Spain· ES:113886002
RELVAR ELLIPTA 92 MCG/22 MCG POLVO PARA INHALACION (UNIDODIS)
A medicinal product containing fluticasona + vilanterol, registered in Spain by Glaxosmithkline Trading Services Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- fluticasona + vilanterol
- Manufacturer
- Glaxosmithkline Trading Services Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo70081130EUR 44.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluticasona + vilanterol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhalerJ M McGill Ltd
- FinlandRelvar ElliptaGlaxosmithkline Trading Services Limited
- NorwayRelvar Ellipta2care4 ApS
- SwedenRELVAR ELLIPTA 184 mikrogram/22 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- SwitzerlandRelvar Ellipta 184/22 mcg, Einzeldosiertes Pulver zur InhalationGlaxoSmithKline AG
- PolandRelvar ElliptaGlaxoSmithKline (Ireland) Limited
- CanadaBREO ELLIPTAGLAXOSMITHKLINE INC
- IrelandRevinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Relvar Ellipta, Revinty Ellipta
- Liechtenstein · Relvar Ellipta, Revinty Ellipta
- Norway · Relvar Ellipta, Revinty Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffa9fcf3-7035-4f84-8b16-b15e723b1813 GET /v1/drugs/ffa9fcf3-7035-4f84-8b16-b15e723b1813?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1386802800000}",
"nregistro": "113886002",
"substance": "fluticasona + vilanterol"
}See everything about fluticasona + vilanterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.